NUMB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.765600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.748400E-01
Normal-vs-Stage2
7.753200E-01
Normal-vs-Stage3
1.823620E-01
Normal-vs-Stage4
5.105800E-01
Stage1-vs-Stage2
6.489800E-01
Stage1-vs-Stage3
3.599600E-01
Stage1-vs-Stage4
4.850200E-01
Stage2-vs-Stage3
6.734400E-02
Stage2-vs-Stage4
3.547000E-01
Stage3-vs-Stage4
1.489990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.803400E-01
Normal-vs-AfricanAmerican
9.546800E-01
Normal-vs-Asian
8.746400E-01
Caucasian-vs-AfricanAmerican
7.615600E-01
Caucasian-vs-Asian
5.373000E-01
AfricanAmerican-vs-Asian
9.060000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.568600E-01
Normal-vs-Female
9.063400E-01
Male-vs-Female
8.055400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.118000E-01
Normal-vs-Age(41-60Yrs)
5.270400E-01
Normal-vs-Age(61-80Yrs)
9.607200E-01
Normal-vs-Age(81-100Yrs)
9.951600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.394400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.200200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.026600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.415900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.511800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.349200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.841600E-01
Normal-vs-Daily Drinker
7.315400E-01
Normal-vs-Weekly Drinker
8.387400E-01
Normal-vs-Occasional Drinker
5.321400E-01
Normal-vs-Social Drinker
8.048200E-01
Non Drinker-vs-Daily Drinker
6.720800E-01
Non Drinker-vs-Weekly Drinker
8.208600E-01
Non Drinker-vs-Occasional Drinker
1.359380E-01
Non Drinker-vs-Social Drinker
5.110200E-01
Daily Drinker-vs-Weekly Drinker
9.274800E-01
Daily Drinker-vs-Occasional Drinker
7.738200E-02
Daily Drinker-vs-Social Drinker
3.054000E-01
Weekly Drinker-vs-Occasional Drinker
2.083800E-01
Weekly Drinker-vs-Social Drinker
5.109600E-01
Occasional Drinker-vs-Social Drinker
3.950000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.296000E-02
Normal-vs-Grade 2
5.200100E-03
Normal-vs-Grade 3
6.843500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.739900E-02
Grade 1-vs-Grade 3
1.130140E-02
Grade 1-vs-Grade 4
9.296000E-02
Grade 2-vs-Grade 3
9.755500E-02
Grade 2-vs-Grade 4
5.200100E-03
Grade 3-vs-Grade 4
6.843500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.920400E-01
Normal-vs-NonDiabetic
9.220600E-01
Diabetic-vs-NonDiabetic
4.540000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.944400E-01
Normal-vs-NoPancreatitis
9.562400E-01
Pancreatitis-vs-NoPancreatitis
3.543600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.865000E-01
Normal-vs-N1
7.413200E-01
N0-vs-N1
1.037620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.717400E-01
Normal-vs-TP53-NonMutant
9.121600E-01
TP53-Mutant-vs-TP53-NonMutant
2.937000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
